论文信息 - A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. - 字舞流文

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease.

S. Schreiber | P. Rutgeerts | M. Kamm | C. Bernstein | R. Fedorak | M. Khaliq-Kareemi | M. Boivin | M. Staun | O. Thomsen | A. Innes | S. Schreiber